Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells

Leila Akkari began her independent career in 2017 as an Assistant Professor at the Netherlands Cancer Institute in Amsterdam after working at Memorial Sloan Kettering Cancer Center in NYC. Two years ago, she was selected as one of the junior members of the Oncode Institute, a virtual group of cancer...

Descripción completa

Guardado en:
Detalles Bibliográficos
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/629c0b3d4b2c4a6a91d38d13225d42c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:629c0b3d4b2c4a6a91d38d13225d42c8
record_format dspace
spelling oai:doaj.org-article:629c0b3d4b2c4a6a91d38d13225d42c82021-12-02T16:49:07ZTargeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells10.1038/s42003-021-02092-32399-3642https://doaj.org/article/629c0b3d4b2c4a6a91d38d13225d42c82021-05-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-02092-3https://doaj.org/toc/2399-3642Leila Akkari began her independent career in 2017 as an Assistant Professor at the Netherlands Cancer Institute in Amsterdam after working at Memorial Sloan Kettering Cancer Center in NYC. Two years ago, she was selected as one of the junior members of the Oncode Institute, a virtual group of cancer research labs based on the Netherlands. In this short Q&A, she tells us about her research and how her diverse background has helped her as a scientist. Dr. Akkari also shares some great pointers on the biggest hurdles women in STEM face and tips to overcome them.Nature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-2 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
description Leila Akkari began her independent career in 2017 as an Assistant Professor at the Netherlands Cancer Institute in Amsterdam after working at Memorial Sloan Kettering Cancer Center in NYC. Two years ago, she was selected as one of the junior members of the Oncode Institute, a virtual group of cancer research labs based on the Netherlands. In this short Q&A, she tells us about her research and how her diverse background has helped her as a scientist. Dr. Akkari also shares some great pointers on the biggest hurdles women in STEM face and tips to overcome them.
format article
title Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_short Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_full Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_fullStr Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_full_unstemmed Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_sort targeting the undruggable: an interview with leila akkari on fighting cancer by rewiring cells
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/629c0b3d4b2c4a6a91d38d13225d42c8
_version_ 1718383399542980608